Cancer immunoediting by melanocyte differentiation antigen-specific T cells determines response to immune checkpoint inhibition
Lukas Flatz(Leman University), Michael Hölzel(University of Bonn)
Cited by 0
Related Papers
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
|Nature Immunology|2017|639
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|269
Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036
|European Journal of Cancer|2021|150
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
|Journal for ImmunoTherapy of Cancer|2019|85
Druggable epigenetic suppression of interferon-induced chemokine expression linked to <i>MYCN</i> amplification in neuroblastoma
|Journal for ImmunoTherapy of Cancer|2021|39